Savara Inc. (Nasdaq: SVRA) (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, ...
Savara Inc. (Nasdaq: SVRA), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced ...
Bristol Myers Squibb (NYSE: BMY) today announced the U.S. Food and Drug Administration (FDA) has granted accelerated approval ...
To reduce this risk, individuals should avoid smoking and take steps to stay warm and healthy during cold weather, such as wearing appropriate clothing and practicing good hand hygiene. This article ...
Cediranib maleate is under clinical development by AstraZeneca and currently in Phase II for Small-Cell Lung Cancer.
Cediranib maleate is under clinical development by AstraZeneca and currently in Phase II for Triple-Negative Breast Cancer (TNBC).
Aileron’s lead product candidate, LTI-03, is a novel, synthetic peptide with a dual mechanism targeting alveolar epithelial cell survival as well as inhibition of profibrotic signaling. Currently, LTI ...
Aileron's lead product candidate, LTI-03, is a novel, synthetic peptide with a dual mechanism targeting alveolar epithelial cell survival as well as inhibition of profibrotic signaling. Currently, LTI ...
Fact checked by Nick Blackmer Gas stoves can generate 75% of the nitrogen dioxide exposure limits set by the World Health ...